Sponsor Dossier
Wockhardt Bio
Sponsor Dossier for Wockhardt Bio. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AMIKACIN
- Brand: AMIWOK
- Brand: APOMORPHINE
- Brand: APOWOK
- Brand: DAPTOMYCIN
- Brand: DOCETAXEL
- Brand: ICATIBANT
- Brand: IRINOTECAN
- Device (sponsor): Hypodermic needle, single-use, sterile
- Device (sponsor): Sentinel lymph node dye
- Device (sponsor): Perioperative methylene blue stain
- Device (sponsor): Disinfectant, <specify>
- Device (sponsor): Disinfectant, <specify>
- Device (sponsor): Disinfectant, <specify>
- Device (sponsor): Nasal irrigation applicator
- Device (sponsor): Disinfectant, <specify>
- Device (sponsor): Disinfectant, <specify>
About
Wockhardt Bio is an Australian Private Company with ABN 91607752090, registered in New South Wales. The entity is active and registered for GST.
Portfolio
Wockhardt Bio holds 15 brands on the ARTG, of which 11 are indexable. Ten brands have Product Information on file. One brand has a PBAC outcome on record, and none have AusPARs on record. Notable brands in the portfolio include Amikacin, Amiwok, Apomorphine, Apowok, Daptomycin, Docetaxel, Icatibant, Irinotecan, Metaraminol, Oxaliplatin, Oxycodone, and Sodium formulations.
Therapeutic focus —
Infectious Disease: 5 brands — Neurology: 4 brands — Oncology: 4 brands — Rare Disease: 1 brand — Pain & Anaesthesia: 1 brand
Regulatory activity
Wockhardt Bio has one brand with a PBAC outcome on record, with the latest outcome dated 1 November 2020. The portfolio contains no brands with AusPARs on record.